Increased PD-1+ cells in tumor biopsies have been associated with either favorable prognosis in patients with follicular lymphoma (31, 32), lung cancer (33), ovarian cancer (34), or poor survival in cancer patients (35, 36). This evidence concerns the gene PDCD1 and follicular lymphoma.